KKR Associates North America XI L.P.

CIK 1619837 · last filed 2024-05-28

KKR Associates North America XI L.P. is a corporate insider who has filed 8 SEC Form 4 insider transactions across 4 companies since 2016. The most recent filing shows the insider sold $1.09B of BV on May 28, 2024. Across all open-market trades the lifetime net is −$14.05B, making them a net seller over the disclosed history. Current disclosed insider exposure totals $4.50B across reported positions. The firm reports its address in New York, NY. 24 SEC filings were submitted jointly with KKR North America Fund XI L.P.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Disclosed Exposure

$4.50B

Companies

4

Total Filings

8

Lifetime Open-Market Net

-$14.05B

Filer Profile

Reported Address

9 WEST 57TH STREET, SUITE 4200
NEW YORK, NY 10019

Phone

(212) 230-9742

Related Filers

KKR North America Fund XI L.P. — 24 joint filings, latest 2025-06-10

KKR North America XI Ltd — 24 joint filings, latest 2025-06-10

KKR Renaissance Aggregator GP LLC — 7 joint filings, latest 2021-05-17

KKR Vision Aggregator GP LLC — 7 joint filings, latest 2019-08-14

KKR PRA Investors GP II LLC — 5 joint filings, latest 2018-08-13

KKR BrightView Aggregator L.P. — 4 joint filings, latest 2025-06-10

Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.

Symbol	Role	Shares	Price	Disclosed Exposure	Lifetime OM Net	Filings	Latest Filed
BV	10%+ Owner	33,133,123	$11.22	$371.92M	-$1.61B	2	2024-05-28
IR	10%+ Owner	56,888,635	$72.48	$4.12B	-$1.99B	1	2020-05-29
EYE	10%+ Owner	0	$17.53	$0	-$3.59B	2	2019-08-14
PRA Health Sciences, Inc. (PRAH) Delisted	10%+ Owner	13,195,984	$165.21	$2.18B	-$6.87B	3	2017-08-16

Recent Filings

8 filings

Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.

Filed	Symbol	Action	Net Shares	Net $	Link
2024-05-28	BV	Sell (S)	−87,500,000	-$1.09B	EDGAR
2020-06-17	BV	Sell (S)	−38,925,615	-$515.76M	EDGAR
2020-05-29	IR	Sell (S)	−68,912,500	-$1.99B	EDGAR
2019-08-14	EYE	Sell (S)	−45,749,540	-$1.40B	EDGAR
2018-08-01	EYE	Sell (S)	−57,261,605	-$2.19B	EDGAR
2017-08-16	PRA Health Sciences, Inc. (PRAH) Delisted	Sell (S)	−57,000,000	-$4.27B	EDGAR
2016-05-10	PRA Health Sciences, Inc. (PRAH) Delisted	Sell (S)	−29,446,152	-$1.38B	EDGAR
2016-03-10	PRA Health Sciences, Inc. (PRAH) Delisted	Sell (S)	−28,979,886	-$1.22B	EDGAR

Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.